Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?

World Journal of Surgery

Volumn 34, Issue 10, 2010, Pages 2393-2398

  Crumley, Andrew B C ^a   Stuart, Robert C ^a   McKernan, Margaret ^a   McMillan, Donald C ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; C REACTIVE PROTEIN;

AGED; ARTICLE; BLOOD; FEMALE; HUMAN; HYPOALBUMINEMIA; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; STOMACH TUMOR; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; ALBUMINS; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYPOALBUMINEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77957167774     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0641-y     Document Type: Article

References (27)

1. Cancer Research UK Information Resource Centre (2004) CancerStats. http://info.cancerresearchuk.org/cancerstats
2. H Allgayer MM Heiss FW Schildberg 1997 Prognostic factors in gastric cancer Br J Surg 84 1651 1664 1:STN:280:DyaK1c7htVSlsg%3D%3D 10.1002/bjs.1800841206 9448610
3. S Pyrhonen T Kuitunen P Nyandoto, et al. 1995 Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer Br J Cancer 71 587 591 1:STN:280:DyaK2M7os1ertg%3D%3D 7533517
4. P Ross M Nicolson D Cunningham, et al. 2002 Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer J Clin Oncol 20 1996 2004 1:CAS:528:DC%2BD38XjvVKmsrw%3D 10.1200/JCO.2002.08.105 11956258
5. YC Lien CC Hsieh YC Wu, et al. 2004 Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia J Gastrointest Surg 8 1041 1048 10.1016/j.gassur.2004.09.033 15585392
6. LF Onate-Ocana V Aiello-Crocifoglio D Gallardo-Rincon, et al. 2007 Serum albumin as a significant prognostic factor for patients with gastric carcinoma Ann Surg Oncol 14 381 389 10.1245/s10434-006-9093-x 17160496
7. S Alici S Kaya M Izmirli, et al. 2006 Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma Med Sci Monit 12 CR221 CR229 16641880
8. J Lee T Lim JE Uhm, et al. 2007 Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma Ann Oncol 18 886 891 1:STN:280:DC%2BD2s3ns1Klsg%3D%3D 10.1093/annonc/mdl501 17298958
9. LF Onate-Ocana M Becker JF Carrillo, et al. 2008 Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma J Surg Oncol 98 336 342 10.1002/jso.21118 18646043
10. DC McMillan JE Crozier K Canna, et al. 2007 Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer Int J Colorectal Dis 22 881 886 10.1007/s00384-006-0259- 6 17245566
11. AM Al Murri JM Bartlett PA Canney, et al. 2006 Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer Br J Cancer 94 227 230 1:STN:280:DC%2BD28%2FksFahtw%3D%3D 10.1038/sj.bjc.6602922 16404432
12. LM Forrest DC McMillan CS McArdle, et al. 2003 Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer Br J Cancer 89 1028 1030 1:STN:280:DC%2BD3svisVOjsg%3D%3D 10.1038/sj.bjc.6601242 12966420
13. P Glen NB Jamieson DC McMillan, et al. 2006 Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer Pancreatology 6 450 453 10.1159/000094562 16847382
14. DC McMillan WS Watson P O'Gorman, et al. 2001 Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss Nutr Cancer 39 210 213 1:CAS:528:DC%2BD3MXpt1Wht7s%3D 10.1207/S15327914nc392-8 11759282
15. JR Siewert HJ Stein 1998 Classification of adenocarcinoma of the oesophagogastric junction Br J Surg 85 1457 1459 1:STN:280: DyaK1M%2FjvFGjug%3D%3D 10.1046/j.1365-2168.1998.00940.x 9823902
16. M Maltoni A Caraceni C Brunelli, et al. 2005 Prognostic factors in advanced cancer patients: evidence-based clinical recommendations: a study by the Steering Committee of the European Association for Palliative Care J Clin Oncol 23 6240 6248 10.1200/JCO.2005.06.866 16135490
17. LH Ellegard IG Bosaeus 2008 Biochemical indices to evaluate nutritional support for malignant disease Clin Chim Acta 390 23 27 1:STN:280: DC%2BD1c7lt1aisQ%3D%3D 10.1016/j.cca.2008.01.014 18230351
18. DC McMillan 2008 An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer Proc Nutr Soc 67 257 262 10.1017/S0029665108007131 18452641
19. JE Morley DR Thomas MM Wilson 2006 Cachexia: pathophysiology and clinical relevance Am J Clin Nutr 83 735 743 1:CAS:528:DC%2BD28XjvFWis7g%3D 16600922
20. KC Fearon AC Voss DS Hustead 2006 Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis Am J Clin Nutr 83 1345 1350 1:CAS:528:DC%2BD28XlvFCmtbg%3D 16762946
21. T Ashizawa R Okada Y Suzuki, et al. 2005 Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor Gastric Cancer 8 124 131 1:CAS:528:DC%2BD2MXjvVCntbc%3D 10.1007/s10120-005-0315-x 15864720
22. WC Liao JT Lin CY Wu, et al. 2008 Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma Clin Cancer Res 14 428 434 1:CAS:528:DC%2BD1cXhtVKitb4%3D 10.1158/1078-0432.CCR-07-1032 18198221
23. M Ikeguchi T Hatada M Yamamoto, et al. 2009 Serum interleukin-6 and -10 levels in patients with gastric cancer Gastric Cancer 12 95 100 1:CAS:528:DC%2BD1MXnvVWqsrg%3D 10.1007/s10120-009-0509-8 19562463
24. DK Kim SY Oh HC Kwon, et al. 2009 Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer BMC Cancer 9 155 10.1186/1471-2407-9-155 19457231
25. CY Xu JG Shen JY Shen, et al. 2009 Ulcer size as a novel indicator marker is correlated with prognosis of ulcerative gastric cancer Dig Surg 26 312 316 1:CAS:528:DC%2BD1MXhsVCntbjJ 10.1159/000231881 19657193
26. DA Deans SJ Wigmore AC de Beaux, et al. 2007 Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer Br J Surg 94 1501 1508 1:STN:280:DC%2BD2snpsVektw%3D%3D 10.1002/bjs.5849 17703501
27. AB Crumley RC Stuart M McKernan, et al. 2010 Comparison of pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system J Gastrointest Surg 14 781 787 10.1007/s11605-010-1162-6 20148314